NMR vs. BN
NMR (Nomura Holdings, Inc.) and BN (Brookfield Corporation) are both stocks. Both are in the Financial Services sector — NMR in Capital Markets, BN in Asset Management. Over the past 10 years, NMR returned 10.27%/yr vs 14.55%/yr for BN. At a 0.30 correlation, their price movements are largely independent.
Performance
NMR vs. BN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NMR achieves a 2.26% return, which is significantly higher than BN's -3.44% return. Over the past 10 years, NMR has underperformed BN with an annualized return of 10.27%, while BN has yielded a comparatively higher 14.55% annualized return.
NMR
- 1D
- 2.02%
- 1M
- 7.92%
- YTD
- 2.26%
- 6M
- 10.00%
- 1Y
- 40.79%
- 3Y*
- 37.17%
- 5Y*
- 13.07%
- 10Y*
- 10.27%
BN
- 1D
- -0.83%
- 1M
- -6.05%
- YTD
- -3.44%
- 6M
- -4.46%
- 1Y
- 13.31%
- 3Y*
- 28.82%
- 5Y*
- 11.64%
- 10Y*
- 14.55%
NMR vs. BN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NMR Nomura Holdings, Inc. | 2.26% | 54.10% | 34.05% | 21.84% | -10.28% | -18.76% | 4.39% | 38.71% | -36.08% | 0.16% |
BN Brookfield Corporation | -3.44% | 20.54% | 44.18% | 28.60% | -34.80% | 49.30% | 8.99% | 52.68% | -10.65% | 33.82% |
Correlation
The correlation between NMR and BN is 0.49, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.49 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.47 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.48 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.43 |
Correlation (All Time) Calculated using the full available price history since May 17, 1995 | 0.30 |
The correlation between NMR and BN shifts across timeframes, from 0.30 (all time) to 0.49 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
NMR:
$26.11B
BN:
$104.69B
NMR:
$118.76
BN:
$0.56
NMR:
0.07
BN:
78.31
NMR:
0.00
BN:
171.62
NMR:
0.01
BN:
1.36
NMR:
0.01
BN:
2.44
NMR:
$4.76T
BN:
$76.58B
NMR:
$2.17T
BN:
$27.02B
NMR:
$608.09B
BN:
$31.07B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NMR vs. BN — Risk / Return Rank
NMR
BN
NMR vs. BN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nomura Holdings, Inc. (NMR) and Brookfield Corporation (BN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NMR | BN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.92 | ||
| Sortino ratioReturn per unit of downside risk | +1.11 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.10 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 1.83 | 0.61 | +1.22 |
| Martin ratioReturn relative to average drawdown | 4.67 | 1.68 | +2.98 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NMR | BN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.39 | 0.47 | +0.92 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.44 | 0.37 | +0.07 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.34 | 0.48 | -0.15 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.00 | 0.30 | -0.31 |
Drawdowns
NMR vs. BN - Drawdown Comparison
The maximum NMR drawdown since its inception was -89.27%, which is greater than BN's maximum drawdown of -82.22%. Use the drawdown chart below to compare losses from any high point for NMR and BN.
Loading charts...
Drawdown Indicators
| NMR | BN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.27% | -82.22% | -7.05% |
Max Drawdown (1Y)Largest decline over 1 year | -22.43% | -22.05% | -0.38% |
Max Drawdown (3Y)Largest decline over 3 years | -26.34% | -27.84% | +1.50% |
Max Drawdown (5Y)Largest decline over 5 years | -42.87% | -41.85% | -1.02% |
Max Drawdown (10Y)Largest decline over 10 years | -55.34% | -51.42% | -3.92% |
Current DrawdownCurrent decline from peak | -57.85% | -9.89% | -47.96% |
Average DrawdownAverage peak-to-trough decline | -61.51% | -28.52% | -32.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.77% | 7.93% | +0.84% |
Volatility
NMR vs. BN - Volatility Comparison
The current volatility for Nomura Holdings, Inc. (NMR) is 6.72%, while Brookfield Corporation (BN) has a volatility of 9.72%. This indicates that NMR experiences smaller price fluctuations and is considered to be less risky than BN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NMR | BN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.72% | 9.72% | -3.00% |
Volatility (6M)Calculated over the trailing 6-month period | 22.62% | 22.37% | +0.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.56% | 28.67% | +0.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.68% | 31.24% | -1.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 30.71% | 30.20% | +0.51% |
Dividends
NMR vs. BN - Dividend Comparison
NMR's dividend yield for the trailing twelve months is around 2.03%, more than BN's 0.57% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BN Brookfield Corporation | 0.57% | 0.52% | 0.56% | 0.70% | 1.44% | 1.12% | 1.55% | 1.11% | 1.56% | 1.29% | 1.58% | 1.50% |
NMR Nomura Holdings, Inc. | 2.03% | 4.91% | 4.29% | 1.20% | 3.86% | 0.00% | 0.86% | 0.00% | 0.00% | 1.70% | 1.79% | 3.34% |
Financials
NMR vs. BN - Financials Comparison
This section allows you to compare key financial metrics between Nomura Holdings, Inc. and Brookfield Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NMR vs. BN - Profitability Comparison
NMR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nomura Holdings, Inc. reported a gross profit of 723.15B and revenue of 1.36T. Therefore, the gross margin over that period was 53.2%.
BN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Brookfield Corporation reported a gross profit of 4.43B and revenue of 18.39B. Therefore, the gross margin over that period was 24.1%.
NMR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nomura Holdings, Inc. reported an operating income of 107.67B and revenue of 1.36T, resulting in an operating margin of 7.9%.
BN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Brookfield Corporation reported an operating income of 4.39B and revenue of 18.39B, resulting in an operating margin of 23.9%.
NMR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nomura Holdings, Inc. reported a net income of 73.93B and revenue of 1.36T, resulting in a net margin of 5.4%.
BN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Brookfield Corporation reported a net income of 100.59M and revenue of 18.39B, resulting in a net margin of 0.6%.
Frequently Asked Questions
NMR and BN have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BN has higher volatility (9.72%) compared to NMR (6.72%). In terms of maximum drawdown, NMR dropped -89.27% vs BN's -82.22%.
NMR currently has the higher Sharpe Ratio (1.39 vs 0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NMR and BN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer